Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Instylla, Inc. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

46 daysmedian FDA review time
262 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K261610Verge™ MicrocatheterInstylla, Inc.2026-06-11280
K253769Instylla Delivery KitInstylla, Inc.2025-12-22270
K253677Tembo Embolic SystemInstylla, Inc.2025-12-15240
K240873TEMBO Embolic SystemInstylla, Inc.2024-12-162620
K213632Instylla Delivery KitInstylla, Inc.2022-02-10850
K210808Instylla Microcatheter 1.2Instylla, Inc.2021-04-15290
K202544Instylla Delivery KitInstylla, Inc.2021-01-071270
K200744Instylla MicrocatheterInstylla, Inc.2020-04-21290
K191659Instylla Delivery KitInstylla, Inc.2019-10-101110
K191731Instylla MicrocatheterInstylla, Inc.2019-08-13460

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda